MASSDEVICE ON CALL — Medical device industry lobby AdvaMed isn’t going to let regulatory setbacks and the impending onset of the medical device tax discourage its attempts to repeal the levy.
The group plans to continue garnering support for repeal, but has back-up plans in place in case the tax remains in place, AdvaMed CEO Stephen Ubl told an audience at the AdvaMed 2012 MedTech Conference in Boston this week.
"We’ve seen considerable Senate support for the repeal, and it seems to be growing," Ubl told attendees. "If it doesn’t happen – although I don’t like to speculate – there are corporate tax reforms that could be enacted."
Ubl and AdvaMed board chairman David Dvorak emphasized the group’s position that the device tax will harm innovation and impact jobs, MD+DI reported.
Will the device tax hurt app-makers?
Sen. Evan Bayh (D-Ind.) makes the case that the 2.3% medical device tax taking effect in January will not only hurt medical device companies, but makers of mobile apps for healthcare services, should the IRS determine that the apps qualify as medical devices.
Read more
U.S. breast implant market more attractive than EU
The European breast implant market is poised to remain flat through 2016, while the U.S. will grow modestly, with both together comprising a $1.1 billion value by that year, market analysts predicted.
Read more
Nanobots vs. cancer
Researchers working with tiny nanobots that travel through the blood stream to penetrate deeper than catheters can reach without invasive surgery are exploring ways that robotics can revolutionize cancer treatment, even provide a potential "cure."
Read more
Healthcare providers no better than patients in inhaler technique
Healthcare providers aren’t a good source of information for patients who need to learn how to use their inhalers, according to a study in the British Medical Journal.
Read more
